• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒林酸的多晶型:一种新多晶型物和三种新溶剂化物的分离与表征

Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates.

作者信息

Tros de Ilarduya M C, Martín C, Goñi M M, Martínez-Ohárriz M C

机构信息

Department of Physical Chemistry, School of Pharmacy, University of Navarra, Pamplona, Spain.

出版信息

J Pharm Sci. 1997 Feb;86(2):248-51. doi: 10.1021/js9601748.

DOI:10.1021/js9601748
PMID:9040104
Abstract

The polymorphism of sulindac was investigated. Two polymorphs (I and II) and a new crystalline form (form III) of sulindac were prepared by recrystallization in different solvents. In addition, three new pseudopolymorphs (solvates) from acetone, chloroform, and benzene were obtained, with each containing 1 mol of solvent to 2 mol of sulindac. Different sulindac polymorphs and pseudopolymorphs were characterized by X-ray diffractometry, infrared spectroscopy, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and hot-stage microscopy. The transition behavior of the crystalline forms of sulindac, their melting points, and their enthalpies were investigated by DSC. The melting of form II was observed at 184 degrees C, and form I subsequently recrystallized from this melt. Similarly, form III melts at 145 degrees C and then recrystallizes to form I. We also investigated the influence of the crystallization solvent on sulindac crystal shape.

摘要

对舒林酸的多晶型现象进行了研究。通过在不同溶剂中重结晶制备了舒林酸的两种多晶型物(I型和II型)以及一种新的晶型(III型)。此外,还获得了来自丙酮、氯仿和苯的三种新的假多晶型物(溶剂化物),每种均含有1摩尔溶剂与2摩尔舒林酸。通过X射线衍射法、红外光谱法、差示扫描量热法(DSC)、热重分析(TGA)和热台显微镜对不同的舒林酸多晶型物和假多晶型物进行了表征。通过DSC研究了舒林酸晶型的转变行为、熔点及其焓。观察到II型在184℃熔化,然后I型从该熔体中重结晶。类似地,III型在145℃熔化,然后重结晶形成I型。我们还研究了结晶溶剂对舒林酸晶体形状的影响。

相似文献

1
Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates.舒林酸的多晶型:一种新多晶型物和三种新溶剂化物的分离与表征
J Pharm Sci. 1997 Feb;86(2):248-51. doi: 10.1021/js9601748.
2
Evidence for polymorphism in glisentide.格列净肽存在多态性的证据。
Int J Pharm. 1999 Sep 20;186(2):199-204. doi: 10.1016/s0378-5173(99)00162-3.
3
Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.双氟尼酸的多晶型:一种新晶型的分离及固态特性
J Pharm Sci. 1994 Feb;83(2):174-7. doi: 10.1002/jps.2600830212.
4
Solid state characterization of dehydroepiandrosterone.脱氢表雄酮的固态表征
J Pharm Sci. 1995 Oct;84(10):1169-79. doi: 10.1002/jps.2600841007.
5
Polymorphism of 1,2-dihydro-6-neopentyl-2-oxonicotinic acid: characterization, interconversion, and quantitation.1,2-二氢-6-新戊基-2-氧代烟酸的多态性:表征、相互转化及定量分析
Pharm Res. 1987 Oct;4(5):429-32. doi: 10.1023/a:1016498731952.
6
Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.使用超临界抗溶剂(SAS)工艺对氟康唑进行重结晶。
Int J Pharm. 2007 Jan 10;328(2):152-60. doi: 10.1016/j.ijpharm.2006.08.005. Epub 2006 Aug 12.
7
Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.通过溶剂重结晶制备的齐墩果酸非溶剂化物和溶剂化物的物理表征。
Int J Pharm. 2008 May 1;355(1-2):195-202. doi: 10.1016/j.ijpharm.2007.12.005. Epub 2007 Dec 15.
8
Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.3-氨基-1-(间三氟甲基苯基)-6-甲基-1H-哒嗪-4-酮的多晶型物和溶剂化物的表征
J Pharm Sci. 1992 Aug;81(8):836-41. doi: 10.1002/jps.2600810824.
9
Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.姜黄素两种多晶型物在有机溶剂中的溶解度和晶体成核
J Pharm Sci. 2015 Jul;104(7):2183-9. doi: 10.1002/jps.24463. Epub 2015 May 6.
10
Olanzapine solvates.奥氮平溶剂化物。
J Pharm Sci. 2013 Nov;102(11):4046-56. doi: 10.1002/jps.23714. Epub 2013 Aug 20.

引用本文的文献

1
Physicochemical Stability of Doravirine (Pifeltro): Characterization of Main Degradation Products and Assessment of Stability of Tablets Repackaged in Single-Dose Unit Containers.多拉韦林(Pifeltro)的物理化学稳定性:主要降解产物的表征及重新包装于单剂量单位容器中的片剂稳定性评估。
Pharmaceutics. 2024 Jul 24;16(8):977. doi: 10.3390/pharmaceutics16080977.
2
Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica.用APTES修饰的SBA-15介孔二氧化硅对难溶性舒林酸释放的改性
Pharmaceutics. 2021 Oct 15;13(10):1693. doi: 10.3390/pharmaceutics13101693.
3
New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer-induced heteronucleation.
聚合物诱导异相成核促进镇痛药氟比洛芬和舒林酸新晶型的发现。
J Pharm Sci. 2007 Nov;96(11):2978-86. doi: 10.1002/jps.20954.